Development of antibiotic loaded mesoporous bioactive glass and its drug release kinetics
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Aerogels and thermal insulation · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Twenty-first century challenges for biomaterials10.1098/rsif.2010.0151.focus ↗
2. Mesoporous bioactive glass as a drug delivery system: fabrication, bactericidal properties and biocompatibility10.1007/s10856-013-4960-z ↗
3. Bucholz · 1989 · 477
4. PLGA/mesoporous silica hybrid structure for controlled drug release10.1016/j.jconrel.2004.04.023 ↗
5. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds10.1098/rsif.2009.0379 ↗
6. The effect of zirconium incorporation on the physiochemical and biological properties of mesoporous bioactive glasses scaffolds10.1016/j.micromeso.2011.03.007 ↗
7. Bioactive calcium phosphate-based glasses and ceramics and their biomedical applications: a review10.1177/2041731417719170 ↗
8. Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity10.1016/j.biomaterials.2012.09.066 ↗
9. Biomimetic scaffolds for tissue engineering10.1002/adfm.201103083 ↗
10. Regenerating bone with bioactive glass scaffolds: a review of in vivo studies in bone defect models10.1016/j.actbio.2017.08.030 ↗
11. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application10.1098/rsfs.2011.0121 ↗
12. Preparation and in vivo biocompatibility studies of different mesoporous bioactive glasses10.1016/j.jmbbm.2018.09.024 ↗
13. Potential of growth factor incorporated mesoporous bioactive glass for in vivo bone regeneration10.1016/j.jmbbm.2018.12.012 ↗
14. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering10.1002/chem.200600226 ↗
15. In situ SAXRD study of sol-gel induced well-ordered mesoporous bioglasses for drug delivery10.1002/jbm.a.31545 ↗
16. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system10.1016/j.jconrel.2005.11.002 ↗
17. Preparation, in vitro bioactivity and drug release property of well-ordered mesoporous 58S bioactive glass10.1016/j.jnoncrysol.2006.10.084 ↗
18. Functionalizing mesoporous bioglasses for long-term anti-osteoporotic drug delivery10.1002/chem.201000137 ↗
19. Ordered mesoporous microspheres for bone grafting and drug delivery10.1021/cm801649z ↗
20. Functional mesoporous bioactive glass nanospheres: synthesis, high loading efficiency, controllable delivery of doxorubicin and inhibitory effect on bone cancer cells10.1039/c3tb20275e ↗
21. A controlled antibiotic release system to prevent orthopedic-implant associated infections: an in vitro study10.1016/j.ejpb.2015.08.007 ↗
22. A rapid, flexible method for incorporating controlled antibiotic release into porous polymethylmethacrylate space maintainers for craniofacial reconstruction10.1039/C5BM00175G ↗
23. Near-infrared laser-mediated drug release and antibacterial activity of gold nanorod-sputtered titania nanotubes10.1177/2041731418790315 ↗
24. Graphene quantum dots capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy10.1002/smll.201602225 ↗
25. Magnetic mesoporous silica nanoparticles coated with thermo-responsive copolymer for potential chemo-and magnetic hyperthermia therapy10.1016/j.micromeso.2017.07.053 ↗
26. Effects of mesoporous bioglass on physicochemical and biological properties of calcium sulfate bone cements10.1016/j.apmt.2017.10.006 ↗
27. The impact of beta-lactamases on the development of novel antimicrobial agents
28. Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial10.1007/s11095-010-0166-y ↗
29. Systematic approach to treat chronic osteomyelitis through localized drug delivery system: bench to bed side10.1016/j.msec.2013.05.036 ↗
30. In vitro microbial efficacy of sulbactomax: a novel fixed dose combination of ceftriaxone sulbactam and ceftriaxone alone10.2174/157488509787081840 ↗
31. Synthesis and physico-chemical characterization of different mesoporous bioactive glass nanopowders: in-vitro SBF activity and cytotoxicity10.1080/0371750X.2018.1465357 ↗
32. Doxorubicin-intercalated nano-hydroxyapatite drug-delivery system for liver cancer: an animal model10.1016/j.ceramint.2013.05.074 ↗
33. Antibiotic susceptibility testing by a standardized single disk method10.1093/ajcp/45.4_ts.493 ↗
34. Effect of aging temperature on the structure, pore morphology and bioactivity of new sol-gel synthesized bioglass10.1016/j.jnoncrysol.2014.06.005 ↗
35. Evaluation of synthetic zeolites as oral delivery vehicle for anti-inflammatory drugs
36. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities10.1002/anie.200460598 ↗
37. Solid-state NMR study of ibuprofen confined in MCM-41 material10.1021/cm061551c ↗
38. Influence of pore size of MCM-41 matrices on drug delivery rate10.1016/j.micromeso.2003.12.012 ↗
39. A new family of mesoporous molecular sieves prepared with liquid crystal templates10.1021/ja00053a020 ↗
40. Mesoporous materials for drug delivery10.1002/anie.200604488 ↗
41. The drug release study of ceftriaxone from porous hydroxyapatite scaffolds10.1208/s12249-009-9265-7 ↗
42. Selection of excipients for the formulation of Ceftriaxone sodium loaded chitosan Nanoparticle through drug-excipient compatibility testing
43. Methods for qualitative analysis of cefazolin sodium raw material and pharmaceutical product
44. Mg-Al layered double hydroxide-methotrexate nanohybrid drug delivery system: evaluation of efficacy10.1016/j.msec.2013.01.047 ↗
45. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering10.1002/chem.200600226 ↗
46. A new method to produce macropores in calcium phosphate cements10.1016/S0142-9612(02)00101-1 ↗